Bulgarian Parliament Passes Bill Banning E-Cigarettes and Nicotine Products

Feb.12
Bulgarian Parliament Passes Bill Banning E-Cigarettes and Nicotine Products
Bulgarian lawmaker proposes comprehensive ban on e-cigarettes and nicotine products in revised tobacco law, gaining unanimous support from parliamentary committee.

According to Epicenter's report on February 11th, the proposed amendment to the Tobacco and Related Products Act submitted by Kostadin Angelov of the Bulgarian political party alliance GERB-SDS has been unanimously approved by the parliamentary Economic Committee.


The legislator proposed in the bill to completely ban the supply, sale, distribution, and advertising of e-cigarettes and similar products, regardless of whether they contain nicotine. Additionally, the proposed amendment to the "Child Protection Act" further prohibits the provision and sale of products containing nicotine to children, such as nicotine pouches, snuff, chewing gum, etc., as well as energy drinks.


He called on lawmakers to support the bill, believing that this will demonstrate the Bulgarian government's determination to address this issue.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
At the inaugural AFN, Dr. Rohan Sequeira and Dr. Alex Wodak emphasized that THR offers a science-based approach to reduce smoking-related harm—not merely as an alternative to cessation. They urged policymakers across Asia to reassess tobacco control and include non-combustible products in public health strategies. This article outlines the scientific foundation of THR, its regional challenges, and growth momentum.2Firsts provided in-depth coverage of the forum.
Sep.09
83 Public Health Experts Urge European Commission: Excessive E-Cigarette Taxes Could Undermine Health Policy
83 Public Health Experts Urge European Commission: Excessive E-Cigarette Taxes Could Undermine Health Policy
Eighty-three international experts in public health and tobacco control have co-signed a letter to the European Commission warning that the forthcoming revision of the Tobacco Excise Directive could seriously harm public health if it imposes high taxes on lower-risk alternatives such as e-cigarettes, heated tobacco, and nicotine pouches. The experts argue that the EU’s stance that “non-combustible nicotine products carry risks comparable to cigarettes” contradicts scientific evidence.
Sep.02 by 2FIRSTS.ai
Singapore Steps Up Vape Crackdown After National Day, 18 Arrested in Two-Day HSA Operation
Singapore Steps Up Vape Crackdown After National Day, 18 Arrested in Two-Day HSA Operation
The Health Sciences Authority (HSA) of Singapore conducted a two-day enforcement operation, seizing 82 e-vaporiser devices and arresting 18 individuals. The move follows Prime Minister Lawrence Wong’s announcement that vaping will be treated as a drug issue, with some devices found to contain dangerous substances such as etomidate and ketamine.
Aug.21 by 2FIRSTS.ai
InterTabac 2025 Insights | Caffeine and nicotine-free pouches hit the stage as white-label manufacturing and big players enter, heating up competition
InterTabac 2025 Insights | Caffeine and nicotine-free pouches hit the stage as white-label manufacturing and big players enter, heating up competition
2Firsts discovers at the 2025 InterTabac Exhibition in Dortmund, Germany that nicotine pouches are a top category.
Sep.24 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Former WHO Director Calls for Parallel Platforms to Advance Tobacco Harm Reduction
Former WHO Director Calls for Parallel Platforms to Advance Tobacco Harm Reduction
Despite 20 years of the WHO’s tobacco control treaty, 8 million people still die from smoking each year. At the Asia Forum on Nicotine, former WHO director Tikki Pang called for independent platforms—outside the WHO’s system—to advance tobacco harm reduction (THR). “Instead of banging our heads against a brick wall, why not go around it?” he said.
Sep.08